Global Opioid Induced Constipation (OIC) Drug Market Status, Trends and COVID-19 Impact
In the past few years, the Opioid Induced Constipation (OIC) Drug market experienced a
huge change under the influence of COVID-19, the global market size of Opioid Induced
Constipation (OIC) Drug reached (2021 Market size XXXX) million $ in 2021 from (2016
Market size XXXX) in 2016 with a CAGR of xx from 2016-2021 is. As of now, the global
COVID-19 Coronavirus Cases have exceeded 200 million, and the global epidemic has been
basically under control, therefore, the World Bank has estimated the global economic
growth in 2021 and 2022. The World Bank predicts that the global economic output is
expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research
on Opioid Induced Constipation (OIC) Drug market and global economic environment, we
forecast that the global market size of Opioid Induced Constipation (OIC) Drug will reach
(2026 Market size XXXX) million $ in 2026 with a CAGR of % from 2021-2026.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Opioid Induced Constipation (OIC) Drug Market
Status, Trends and COVID-19 Impact Report 2021, which provides a comprehensive
analysis of the global Opioid Induced Constipation (OIC) Drug market , This Report covers
the manufacturer data, including: sales volume, price, revenue, gross margin, business
distribution etc., these data help the consumer know about the competitors better. This
report also covers all the regions and countries of the world, which shows the regional
development status, including market size, volume and value, as well as price data. Besides,
the report also covers segment data, including: type wise, industry wise, channel wise etc.
all the data period is from 2015-2021E, this report also provide forecast data from 2021-
2026.
Section 1: 100 USD——Market Overview
Section (2 3): 1200 USD——Manufacturer Detail
Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Section (5 6 7): 700 USD——
Product Type Segmentation
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Application Segmentation
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Channel (Direct Sales, Distribution Channel) Segmentation
Section 8: 500 USD——Market Forecast (2021-2026)
Section 9: 600 USD——Downstream Customers
Section 10: 200 USD——Raw Material and Manufacturing Cost
Section 11: 500 USD——Conclusion
Section 12: Research Method and Data Source
huge change under the influence of COVID-19, the global market size of Opioid Induced
Constipation (OIC) Drug reached (2021 Market size XXXX) million $ in 2021 from (2016
Market size XXXX) in 2016 with a CAGR of xx from 2016-2021 is. As of now, the global
COVID-19 Coronavirus Cases have exceeded 200 million, and the global epidemic has been
basically under control, therefore, the World Bank has estimated the global economic
growth in 2021 and 2022. The World Bank predicts that the global economic output is
expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research
on Opioid Induced Constipation (OIC) Drug market and global economic environment, we
forecast that the global market size of Opioid Induced Constipation (OIC) Drug will reach
(2026 Market size XXXX) million $ in 2026 with a CAGR of % from 2021-2026.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Opioid Induced Constipation (OIC) Drug Market
Status, Trends and COVID-19 Impact Report 2021, which provides a comprehensive
analysis of the global Opioid Induced Constipation (OIC) Drug market , This Report covers
the manufacturer data, including: sales volume, price, revenue, gross margin, business
distribution etc., these data help the consumer know about the competitors better. This
report also covers all the regions and countries of the world, which shows the regional
development status, including market size, volume and value, as well as price data. Besides,
the report also covers segment data, including: type wise, industry wise, channel wise etc.
all the data period is from 2015-2021E, this report also provide forecast data from 2021-
2026.
Section 1: 100 USD——Market Overview
Section (2 3): 1200 USD——Manufacturer Detail
Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Section (5 6 7): 700 USD——
Product Type Segmentation
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Application Segmentation
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Channel (Direct Sales, Distribution Channel) Segmentation
Section 8: 500 USD——Market Forecast (2021-2026)
Section 9: 600 USD——Downstream Customers
Section 10: 200 USD——Raw Material and Manufacturing Cost
Section 11: 500 USD——Conclusion
Section 12: Research Method and Data Source
SECTION 1 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET OVERVIEW
1.1 Opioid Induced Constipation (OIC) Drug Market Scope
1.2 COVID-19 Impact on Opioid Induced Constipation (OIC) Drug Market
1.3 Global Opioid Induced Constipation (OIC) Drug Market Status and Forecast Overview
1.3.1 Global Opioid Induced Constipation (OIC) Drug Market Status 2016-2021
1.3.2 Global Opioid Induced Constipation (OIC) Drug Market Forecast 2021-2026
SECTION 2 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET MANUFACTURER SHARE
2.1 Global Manufacturer Opioid Induced Constipation (OIC) Drug Sales Volume
2.2 Global Manufacturer Opioid Induced Constipation (OIC) Drug Business Revenue
SECTION 3 MANUFACTURER OPIOID INDUCED CONSTIPATION (OIC) DRUG BUSINESS INTRODUCTION
3.1 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Business
Introduction
3.1.1 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales Volume,
Price, Revenue and Gross margin 2016-2021
3.1.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Business
Distribution by Region
3.1.3 Ironwood Pharmaceuticals Interview Record
3.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Business Profile
3.1.5 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product
Specification
3.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Business Introduction
3.2.1 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales Volume, Price,
Revenue and Gross margin 2016-2021
3.2.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Business Distribution by
Region
3.2.3 Interview Record
3.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Business Overview
3.2.5 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Specification
3.3 Manufacturer three Opioid Induced Constipation (OIC) Drug Business Introduction
3.3.1 Manufacturer three Opioid Induced Constipation (OIC) Drug Sales Volume, Price,
Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Opioid Induced Constipation (OIC) Drug Business Distribution by
Region
3.3.3 Interview Record
3.3.4 Manufacturer three Opioid Induced Constipation (OIC) Drug Business Overview
3.3.5 Manufacturer three Opioid Induced Constipation (OIC) Drug Product Specification
SECTION 4 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION (BY REGION)
4.1 North America Country
4.1.1 United States Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis
2016-2021
4.1.2 Canada Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.1.3 Mexico Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.2 South America Country
4.2.1 Brazil Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.2.2 Argentina Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis
2016-2021
4.3 Asia Pacific
4.3.1 China Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.3.2 Japan Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.3.3 India Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.3.4 Korea Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.3.5 Southeast Asia Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis
2016-2021
4.4 Europe Country
4.4.1 Germany Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis
2016-2021
4.4.2 UK Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-2021
4.4.3 France Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.4.4 Spain Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.4.5 Italy Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.5 Middle East and Africa
4.5.1 Africa Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.5.2 Middle East Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis
2016-2021
4.6 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Region)
Analysis 2016-2021
4.7 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Region)
Analysis
SECTION 5 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION (BY PRODUCT
Type)
5.1 Product Introduction by Type
5.1.1 Lubiprostone Product Introduction
5.1.2 Methyl Naltrexone Bromide Product Introduction
5.1.3 Naldemedine Product Introduction
5.1.4 Alvimopan Product Introduction
5.2 Global Opioid Induced Constipation (OIC) Drug Sales Volume by Methyl Naltrexone
Bromide016-2021
5.3 Global Opioid Induced Constipation (OIC) Drug Market Size by Methyl Naltrexone
Bromide016-2021
5.4 Different Opioid Induced Constipation (OIC) Drug Product Type Price 2016-2021
5.5 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Type) Analysis
SECTION 6 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION (BY
Application)
6.1 Global Opioid Induced Constipation (OIC) Drug Sales Volume by Application 2016-2021
6.2 Global Opioid Induced Constipation (OIC) Drug Market Size by Application 2016-2021
6.2 Opioid Induced Constipation (OIC) Drug Price in Different Application Field 2016-2021
6.3 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Application)
Analysis
SECTION 7 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION (BY CHANNEL)
7.1 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Channel) Sales
Volume and Share 2016-2021
7.2 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Channel)
Analysis
1.1 Opioid Induced Constipation (OIC) Drug Market Scope
1.2 COVID-19 Impact on Opioid Induced Constipation (OIC) Drug Market
1.3 Global Opioid Induced Constipation (OIC) Drug Market Status and Forecast Overview
1.3.1 Global Opioid Induced Constipation (OIC) Drug Market Status 2016-2021
1.3.2 Global Opioid Induced Constipation (OIC) Drug Market Forecast 2021-2026
SECTION 2 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET MANUFACTURER SHARE
2.1 Global Manufacturer Opioid Induced Constipation (OIC) Drug Sales Volume
2.2 Global Manufacturer Opioid Induced Constipation (OIC) Drug Business Revenue
SECTION 3 MANUFACTURER OPIOID INDUCED CONSTIPATION (OIC) DRUG BUSINESS INTRODUCTION
3.1 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Business
Introduction
3.1.1 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales Volume,
Price, Revenue and Gross margin 2016-2021
3.1.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Business
Distribution by Region
3.1.3 Ironwood Pharmaceuticals Interview Record
3.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Business Profile
3.1.5 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product
Specification
3.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Business Introduction
3.2.1 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales Volume, Price,
Revenue and Gross margin 2016-2021
3.2.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Business Distribution by
Region
3.2.3 Interview Record
3.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Business Overview
3.2.5 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Specification
3.3 Manufacturer three Opioid Induced Constipation (OIC) Drug Business Introduction
3.3.1 Manufacturer three Opioid Induced Constipation (OIC) Drug Sales Volume, Price,
Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Opioid Induced Constipation (OIC) Drug Business Distribution by
Region
3.3.3 Interview Record
3.3.4 Manufacturer three Opioid Induced Constipation (OIC) Drug Business Overview
3.3.5 Manufacturer three Opioid Induced Constipation (OIC) Drug Product Specification
SECTION 4 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION (BY REGION)
4.1 North America Country
4.1.1 United States Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis
2016-2021
4.1.2 Canada Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.1.3 Mexico Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.2 South America Country
4.2.1 Brazil Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.2.2 Argentina Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis
2016-2021
4.3 Asia Pacific
4.3.1 China Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.3.2 Japan Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.3.3 India Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.3.4 Korea Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.3.5 Southeast Asia Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis
2016-2021
4.4 Europe Country
4.4.1 Germany Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis
2016-2021
4.4.2 UK Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-2021
4.4.3 France Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.4.4 Spain Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.4.5 Italy Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.5 Middle East and Africa
4.5.1 Africa Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis 2016-
2021
4.5.2 Middle East Opioid Induced Constipation (OIC) Drug Market Size and Price Analysis
2016-2021
4.6 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Region)
Analysis 2016-2021
4.7 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Region)
Analysis
SECTION 5 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION (BY PRODUCT
Type)
5.1 Product Introduction by Type
5.1.1 Lubiprostone Product Introduction
5.1.2 Methyl Naltrexone Bromide Product Introduction
5.1.3 Naldemedine Product Introduction
5.1.4 Alvimopan Product Introduction
5.2 Global Opioid Induced Constipation (OIC) Drug Sales Volume by Methyl Naltrexone
Bromide016-2021
5.3 Global Opioid Induced Constipation (OIC) Drug Market Size by Methyl Naltrexone
Bromide016-2021
5.4 Different Opioid Induced Constipation (OIC) Drug Product Type Price 2016-2021
5.5 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Type) Analysis
SECTION 6 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION (BY
Application)
6.1 Global Opioid Induced Constipation (OIC) Drug Sales Volume by Application 2016-2021
6.2 Global Opioid Induced Constipation (OIC) Drug Market Size by Application 2016-2021
6.2 Opioid Induced Constipation (OIC) Drug Price in Different Application Field 2016-2021
6.3 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Application)
Analysis
SECTION 7 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION (BY CHANNEL)
7.1 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Channel) Sales
Volume and Share 2016-2021
7.2 Global Opioid Induced Constipation (OIC) Drug Market Segmentation (By Channel)
Analysis
